Table 1.
Identified FaRPs by two immuno-based methodologies
| [M+H]+ | Sequence | Immuno-dot-blot | Immunoprecipitation |
|---|---|---|---|
| 824.49 | RSFLRFamide | + | - |
| 851.50 | RNFLRFamide | + | + |
| 926.52 | SKNYLRFamide | + | + |
| 938.53 | NRSFLRFamide | + | - |
| 962.53 | pyrRNFLRFamide | + | - |
| 965.54 | NRNFLRFamide | + | + |
| 966.53 | DRNFLRFamide | + | + |
| 1022.56 | GNRNFLRFamide | + | + |
| 1104.61 | GAHKNYLRFamide | + | + |
| 1122.63 | RDRNFLRFamide | + | - |
| 1146.61 | GYSKNYLRFamide | + | + |
| 1147.65 | APQRNFLRFamide | + | + |
| 1172.63 | AYNRSFLRFamide | + | + |
| 1181.62 | SENRNFLRFamide | + | + |
| 977.63 | GPKNFLRFamide | + | + |
| 1005.59 | GPRNFLRFamide | + | + |
| 1101.61 | YNRSFLRFamide | - | + |
Bold type indicates novel peptides detected in our study
+ indicates the presence of a peptide and − indicates absence of peptide signal.